ARTICANZ - Beta (ver 0.9)

Annotated Registry of Trials in Cancer, Australia and New Zealand Ed. - Cancer trials meta-search engine Australia/NZ - Clinical Trials Data and Ontologies

Clinical Trials Data and Ontologies

Access and download data files for cancer clinical trials in Australia and New Zealand.

Cancer Clinical Trials Databases

Resource	Description	Last Updated	API Access	Download
ARTICANZ-trials-summary-advanced.tsv	Distilled Australian / New Zealand Cancer Trials list - Solid tumours / Advanced	2025-04-28	JSON	716.3 KB
ARTICANZ-trials-summary-extra-advanced.tsv	Distilled Australian / New Zealand Cancer Trials list - Solid tumours / Advanced (Extra annotations)	2025-04-28	JSON	1,769.0 KB
ARTICANZ-trials-summary-curative.tsv	Distilled Australian / New Zealand Cancer Trials list - Curative	2025-04-28	JSON	89.2 KB
ARTICANZ-trials-summary-extra-curative.tsv	Distilled Australian / New Zealand Cancer Trials list - Curative (Extra annotations)	2025-04-28	JSON	212.2 KB
ARTICANZ-trials-summary-haem.tsv	Distilled Australian / New Zealand Cancer Trials list - Haematology	2025-04-28	JSON	249.4 KB
ARTICANZ-trials-summary-extra-haem.tsv	Distilled Australian / New Zealand Cancer Trials list - Haematology (Extra annotations)	2025-04-28	JSON	544.8 KB

Ontologies

Resource	Description	Last Updated	API Access	Download
drug_database.txt	Precision cancer drugs ontology (flat file 1). This file is part of the Precision Oncology Treatments and Trials Recommender (POTTR). Data description and OBO format will be release in v1.0.	2025-04-28	Not available	92.1 KB
drug_class_hierarchy.txt	Precision cancer drugs ontology (flat file 2). This file is part of the Precision Oncology Treatments and Trials Recommender (POTTR). Data description and OBO format will be release in v1.0.	2025-04-25	Not available	134.2 KB
cancer_types.txt	Cancer types ontology (flat file). This file is part of the Precision Oncology Treatments and Trials Recommender (POTTR). Data description and OBO format will be release in v1.0.	2025-03-11	Not available	90.2 KB

Data Usage Policy

The data and APIs on this page are provided for research and educational purposes. Please cite ARTICANZ when using these resources in your research.

ARTICANZ (Annotated Registry of Trials in Cancer, Australia/NZ Edition; ARTificial Intelligence-enhanced CANcer trial information database) provides information about cancer drug trials in Australia and New Zealand as a free, open-information platform. Please note the following:

Data Accuracy: While ARTICANZ strives to maintain accurate and up-to-date information through regular weekly updates and specialist review, we cannot guarantee the complete accuracy, reliability, or timeliness of all data. Information may change between updates.
Not Medical Advice: The information provided by ARTICANZ is for informational purposes only and should not be considered medical advice. All clinical decisions should be made in consultation with qualified healthcare professionals.
No Warranty: ARTICANZ is provided "as is" without any warranties, expressed or implied. We disclaim all liability for any damages arising from the use of or inability to use this platform.
External Links: ARTICANZ may contain links to external websites. We are not responsible for the content or privacy practices of these sites.

By using ARTICANZ, you acknowledge that you have read and understood this disclaimer.

The ARTICANZ platform and its contents are made available under the Creative Commons Attribution 4.0 International License (CC BY 4.0).

Users are free to:

Share — copy and redistribute the data in any medium or format
Adapt — remix, transform, and build upon the data
Use the data for any purpose, including commercial use

Under the following terms:

Attribution — You must give appropriate credit to ARTICANZ, provide a link to the license, and indicate if changes were made
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits

Platform developed and currently maintained by Dr. Frank Lin and the ARTICANZ team.